Vision

EpicentRx™
Mission Statement

Harm the Disease Not Patients

EpicentRx™ began with a simple question: “what is the best and most effective way to treat patients?” The answer: in combination. Too often, however, combination therapies harm the patient more than the disease, which was a non-starter for us. This led us to develop a new class of therapies that are intended to target cancer and other chronic diseases both alone and in combination with minimal toxicity and maximum activity.

pulsing dot

Our Mission Statement Defines Our Culture.

Just as patients are best treated in combination with therapies that work together in sync with minimal harm to patients, so our culture aligns around a common, shared objective: team success, which translates to the approval of our drugs, devices, and vaccines hopefully for the benefit of patients without any other—or without any good—treatment options.

Management Team

TONY REID, M.D. Ph.D.
Chief Executive Officer

BIO

BRYAN ORONSKY, M.D. Ph.D.
Chief Development Officer

BIO

FRANCK BRINKHAUS, Ph.D.
President & Chief Financial Officer

BIO

MEAGHAN STIRN
M.B.A
Controller & VP of Special Projects

BIO

CHRIS LARSON
M.D. Ph.D.
Vice President of Viral Therapy

BIO

SCOTT CAROEN
Senior Director of Operations & Corporate Development

BIO

Behind the company’s mission is a group of exceptional people

Founded on a vision for better care

An exceptional leader and true visionary, Arnold Oronsky, Ph.D. founded EpicentRx to change the paradigm of how patients experience treatment. “Arnie” combined a deep understanding of medical research with a passion for improving the lives of patients and an exceptional talent for building teams focused on novel therapeutics. His legacy lives on in the team he assembled and the core mission of EpicentRx.

SUSAN KNOX, M.D.
Associate Professor of Radiation Oncology, Emerita, Stanford University

Stanford Hospital and Clinics, Lucile Packard Children’s Hospital

THEODORE LAWRENCE, M.D., Ph.D.
Chair of the Department of Radiation Oncology, University of Michigan

Isadore Lampe Professor of Radiation Oncology

KENNETH C. ANDERSON, M.D.
Kraft Family Professor of Medicine, Medicine, Harvard Medical School

Physician, Oncology, Brigham And Women’s Hospital

SUSAN KNOX, M.D.
Associate Professor of Radiation Oncology, Emerita, Stanford University

Stanford Hospital and Clinics, Lucile Packard Children’s Hospital

THEODORE LAWRENCE, M.D., Ph.D.
Chair of the Department of Radiation Oncology, University of Michigan

Isadore Lampe Professor of Radiation Oncology

KENNETH C. ANDERSON, M.D.
Kraft Family Professor of Medicine, Medicine, Harvard Medical School

Physician, Oncology, Brigham And Women’s Hospital